glp 1 agonist anti inflammatory Health Feed The Unstoppable Rise of GLP-1

doi: 10.1007/s40265-022-01746-8

BlevinsTPullmanJMalloyJYanPTaylorKSchulteisCet alDURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes

Sellers, Y

Designing small molecules able to target multiple receptors might sound difficult, but Septerna says the allosteric binding site it has discovered is even better conserved across all incretin receptors than the site targeted by peptides and other small molecule drugs

Exenatide BID should be administered within 60 minutes before the two main meals of the day

That's nearly two decades of clinical use before weight loss applications gained attention